Centene Corporation (CNC) Stock
NYSECNC has an Alpha Score of 48 out of 100 (weak), computed on Oct 26, 2026 from 2 of 4 sub-scores. 14 members of Congress disclosed 50 trades in CNC since 2017: 33 purchases and 17 sales, most recently Tim Moore (sale, Aug 18, 2025). 8 of the hedge funds AlphaScala tracks reported CNC in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is D.E. Shaw's at $334.65M. Company insiders reported 0 open-market buys and 2 sales on SEC Form 4 in the 90 days to Oct 30, 2026.
What is CNC's Alpha Score?
How it works →Alpha Score of 47 reflects weak overall profile with strong momentum, weak quality. Based on 2 of 4 signals – score is capped at 75 until remaining data ingests.
Computed from 2 of 4 sub-scores; a sub-score is left out when its inputs are missing, and the composite is capped accordingly.
Computed Oct 26, 2026
A rules-based research rating, not a recommendation to buy or sell.
Which members of Congress traded Centene Corporation (CNC)?
Most recent: Tim Moore (sale, Aug 18, 2025); records start Jul 3, 2017.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Tim Moore R-NC · House | 2025-08-18 | sale | $100k – $250k |
| Tim Moore R-NC · House | 2025-08-08 | purchase | $1k – $15k |
| Julia Letlow R-LA · House | 2025-08-08 | sale | $1k – $15k |
| Tim Moore R-NC · House | 2025-08-07 | purchase | $15k – $50k |
| Gil Cisneros D-CA · House | 2025-08-05 | purchase | $1k – $15k |
| Tim Moore R-NC · House | 2025-07-30 | purchase | $15k – $50k |
| Tim Moore R-NC · House | 2025-07-29 | purchase | $15k – $50k |
| Tim Moore R-NC · House | 2025-07-22 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 29, 2026.
Every member of Congress who traded CNC, with filing lags →Which hedge funds own CNC?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| D.E. Shaw David Shaw | 5.21M | $334.65M | -31% |
| Renaissance Technologies Jim Simons (founder) | 2.19M | $140.73M | +30% |
| Greenlight Capital David Einhorn | 1.65M | $105.99M | -40% |
| Millennium Management Israel Englander | 1.59M | $102.12M | -39% |
| Marshall Wace | 1.27M | $81.69M | +2% |
| Citadel Ken Griffin | 1.01M | $64.66M | -42% |
| Point72 Steve Cohen | 682K | $43.81M | -72% |
| Bridgewater Associates Ray Dalio | 387K | $24.86M | +130% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →Are Centene Corporation insiders buying or selling?
SEC Form 4 filings| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 26, 26 | Koster Christopher | Secretary & General Counsel | SELL | 56.5K | $3.8M |
| Aug 18, 26 | Koster Christopher | Secretary & General Counsel | SELL | 47.6K | $3.1M |
SEC Form 4 filings as of Oct 30, 2026
See cluster-buy signals across all tickers →What are CNC's key statistics?
Key statistics as of Oct 30, 2026
How does CNC's valuation compare with the Healthcare sector?
| Metric | CNC | Healthcare median | Companies in median |
|---|---|---|---|
| Net margin | -3.25% | 5.48% | 139 |
| Return on equity | -24.03% | 6.84% | 158 |
Medians over the Healthcare stocks whose key statistics were refreshed in the last 35 days (newest Nov 2, 2026). P/E excludes loss-making companies.
CNC price chart
Powered by TradingViewWhat does Centene Corporation do?
Centene Corporation is a leading American for-profit healthcare enterprise specializing in managed care services, primarily serving government-sponsored programs like Medicaid, Medicare, and the Health Insurance Marketplace. Headquartered in the Greater St. Louis area, it acts as an intermediary for both government-subsidized and privately insured healthcare, delivering affordable, high-quality coverage to nearly 28 million members across all 50 states—one in every 15 individuals nationwide. Founded in 1984 as a nonprofit Medicaid plan in Wisconsin by Elizabeth Brinn, the company evolved through strategic acquisitions, going public in 2001 and expanding under leaders like Michael Neidorff and current CEO Sarah London since 2022. Its core segments include Medicaid with local plans like Arizona Complete Health and Sunshine Health, commercial products for employer groups and individuals, and specialty services in behavioral health and pharmacy benefits. Ranked among the Fortune 500's top companies by revenue, Centene emphasizes a localized approach with culturally sensitive care, data-driven management, and innovation to address underserved populations, enhancing health equity and community wellness.